Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

31
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
31
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

60
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
60
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

969
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
969
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

1.1K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.1K
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

485
Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
485
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

36
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
36

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atrial Myxoma: Presenting as a Large Splenic Infarction.

Cureus·2024
Same author

Arrhythmogenic Right Ventricular Cardiomyopathy.

The New England journal of medicine·2022
Same author

Posterior Reversible Encephalopathy Syndrome Onset Within 24 Hours Following Moderna mRNA Booster COVID-19 Vaccination: Vaccine Adverse Event Vs. Hypertension?

Cureus·2022
Same author

Coved and Saddleback ST-Segment Elevations: Brugada Phenocopy vs Brugada Syndrome.

Cureus·2022
Same author

A Patient's Six-Month Journey From Low Sodium to Blue Toes to Stroke: Non-infective Thrombotic Endocarditis Due to Non-small Cell Lung Cancer.

Cureus·2022
Same author

Myocarditis Post Moderna Vaccination: Review of Criteria for Diagnosis.

Cureus·2021

Related Experiment Video

Updated: Aug 27, 2025

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
09:25

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells

Published on: August 19, 2016

11.1K

Toxic Shock Syndrome From Group C Streptococcus.

Jocelyn McCullough1, Shehnaz Wasim1, Kuschner Zachary2

  • 1Medical Education, Zucker School of Medicine, Port Jefferson, USA.

Cureus
|September 26, 2022
PubMed
Summary
This summary is machine-generated.

Group C Streptococcus bacteremia can cause severe toxic shock syndrome. Early antibiotics and intravenous immunoglobulin (IVIG) may improve survival in patients with this rare but serious infection.

Keywords:
bullous cellulitiscritical caregram positive bacteremiagroup c streptococcusintravenous immunoglobulins (ivig)toxic-shock syndrome

More Related Videos

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.1K
A Murine Model of Group B Streptococcus Vaginal Colonization
10:19

A Murine Model of Group B Streptococcus Vaginal Colonization

Published on: November 16, 2016

14.5K

Related Experiment Videos

Last Updated: Aug 27, 2025

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
09:25

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells

Published on: August 19, 2016

11.1K
A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats
05:56

A Reproducible Intensive Care Unit-Oriented Endotoxin Model in Rats

Published on: February 20, 2021

2.1K
A Murine Model of Group B Streptococcus Vaginal Colonization
10:19

A Murine Model of Group B Streptococcus Vaginal Colonization

Published on: November 16, 2016

14.5K

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Lower extremity cellulitis is a common presentation requiring prompt treatment.
  • Toxic shock syndrome (TSS) is a severe, life-threatening multisystem illness.
  • Group C Streptococcus is a less common cause of invasive infections compared to other streptococcal species.

Observation:

  • A patient presented with lower extremity cellulitis and subsequently developed Group C Streptococcus bacteremia.
  • The patient exhibited signs and symptoms consistent with toxic shock syndrome.
  • Despite broad-spectrum antibiotics (piperacillin/tazobactam, vancomycin, clindamycin) and subsequent meropenem, the patient's condition worsened.

Findings:

  • Group C Streptococcus was identified as the causative agent of bacteremia and toxic shock syndrome.
  • Treatment included a 14-day course of meropenem and a three-day regimen of intravenous immunoglobulin (IVIG).
  • The patient survived for 46 days post-admission but ultimately did not recover.

Implications:

  • This case highlights the potential for Group C Streptococcus to cause severe invasive disease, including TSS.
  • Timely administration of appropriate antibiotics and adjunctive therapy with IVIG may be crucial for improving outcomes.
  • Increased awareness and prompt management are essential to reduce mortality associated with Group C Streptococcus-induced TSS.